These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16793484)

  • 1. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
    Oh S; Kim SH; Ko Y; Sim JH; Kim KS; Lee SH; Park S; Kim YJ
    Food Chem Toxicol; 2006 Aug; 44(8):1184-90. PubMed ID: 16793484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria.
    Oh S; Kim SH; Ko Y; Sim JH; Kim KS; Lee SH; Park S; Kim YJ
    Food Chem Toxicol; 2006 Apr; 44(4):552-9. PubMed ID: 16226831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial effect of bacteriocin KU24 produced by Lactococcus lactis KU24 against methicillin-resistant Staphylococcus aureus.
    Lee NK; Han EJ; Han KJ; Paik HD
    J Food Sci; 2013 Mar; 78(3):M465-9. PubMed ID: 23398212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The influence of AMPs from HaCaT keratinocytes on some bacteria strains derived from skin changes].
    Wiechuła B; Wilk I; Ekiel A; Tustanowski J; Martirosian G
    Med Dosw Mikrobiol; 2006; 58(2):163-8. PubMed ID: 17133910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial characterization of bacteriocins produced by human Lactococcus lactis and Pediococccus acidilactici isolates.
    Millette M; Dupont C; Archambault D; Lacroix M
    J Appl Microbiol; 2007 Jan; 102(1):274-82. PubMed ID: 17184344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.
    Alba V; Urban E; Angeles Dominguez M; Nagy E; Nord CE; Palacín C; Vila J
    Int J Antimicrob Agents; 2009 Mar; 33(3):272-5. PubMed ID: 19095414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of Fortunella japonica var. margarita and Citrus sunki essential oils on nitric oxide production and skin pathogens.
    Yang EJ; Kim SS; Moon JY; Oh TH; Baik JS; Lee NH; Hyun CG
    Acta Microbiol Immunol Hung; 2010 Mar; 57(1):15-27. PubMed ID: 20350876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD; Jones DG; Sánchez Bruni SF
    Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.
    Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM
    J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the bacteriocin PsVP-10 produced by Pseudomonas sp. on sensitive bacterial strains.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    Rev Latinoam Microbiol; 2002; 44(1):19-23. PubMed ID: 17061511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Propionibacterium acnes and Staphylococcus epidermidis to killing by MPO-halide system products. Implication for taurine bromamine as a new candidate for topical therapy in treating acne vulgaris.
    Marcinkiewicz J; Biedroń R; Białecka A; Kasprowicz A; Mak M; Targosz M
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):61-8. PubMed ID: 16642259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CBT-SL5, a bacteriocin from Enterococcus faecalis, suppresses the expression of interleukin-8 induced by Propionibacterium acnes in cultured human keratinocytes.
    Lee YJ; Choi HJ; Kang TW; Kim HO; Chung MJ; Park YM
    J Microbiol Biotechnol; 2008 Jul; 18(7):1308-16. PubMed ID: 18667861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The assessment of bacterial flora and antibiotic-sensitivity of bacteria isolated from conjunctival sac, skin of the eyelids and inflammatory lesions in patients with acne vulgaris and rosacea].
    Kaszuba-Bartkowiak K; Goś R
    Przegl Lek; 2007; 64(12):991-6. PubMed ID: 18595500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a bacteriocin produced by Prevotella nigrescens ATCC 25261.
    Kaewsrichan J; Douglas CW; Nissen-Meyer J; Fimland G; Teanpaisan R
    Lett Appl Microbiol; 2004; 39(5):451-8. PubMed ID: 15482437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne.
    Gübelin W; Martínez MA; Molina MT; Zapata S; Valenzuela ME
    Rev Latinoam Microbiol; 2006; 48(1):14-6. PubMed ID: 17357569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human skin microbiota is a rich source of bacteriocin-producing staphylococci that kill human pathogens.
    O'Sullivan JN; Rea MC; O'Connor PM; Hill C; Ross RP
    FEMS Microbiol Ecol; 2019 Feb; 95(2):. PubMed ID: 30590567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid systemic and local treatments with the antibacterial peptide dimer A3-APO and its monomeric metabolite eliminate bacteria and reduce inflammation in intradermal lesions infected with Propionibacterium acnes and meticillin-resistant Staphylococcus aureus.
    Ostorhazi E; Voros E; Nemes-Nikodem E; Pinter D; Sillo P; Mayer B; Wade JD; Otvos L
    Int J Antimicrob Agents; 2013 Dec; 42(6):537-43. PubMed ID: 24074727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of skin bacteria: lethality of the wash solution used to remove bacteria.
    Bloom E; Aly R; Maibach HI
    Acta Derm Venereol; 1979; 59(5):460-3. PubMed ID: 93373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.